Table 3.
Changes in SBP and DBP in all subjects with high-normal blood pressure and grade 1 hypertension.
| Placebo | Test | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Weeks | n | Mean | (SD) | n | Mean | (SD) | ΔBP | p | ||
| SBP | 0 | 43 | 140.0 | (7.2) | 43 | 140.3 | (7.9) | 0.3 (−2.9 to 3.5) |
0.8528 | |
| 12 | 42 | 137.1 | (8.9) | 41 | 132.8 | (10.7) | −4.3 (−8.6 to −0.006) |
0.0497 | ||
| DBP | 0 | 43 | 89.4 | (6.1) | 43 | 90.3 | (5.6) | 0.9 (−1.7 to 3.4) |
0.4985 | |
| 12 | 42 | 87.0 | (5.8) | 41 | 87.0 | (8.0) | −0.1 (−3.1 to 3.0) |
0.9687 | ||
Each value is expressed as the mean (SD). ΔBP indicates the difference in the averages of the test group and the placebo group (95% confidence interval). SBP: systolic blood pressure; DBP: diastolic blood pressure.